DEFA14A: Alnylam Pharmaceuticals Sets Date for 2024 Annual Meeting, Outlines Voting Matters

Alnylam Pharmaceuticals announces its 2024 Annual Meeting of Stockholders to be held virtually on May 16, 2024, with voting open until May 15, 2024.

Summary

• Alnylam Pharmaceuticals will hold its Annual Meeting on May 16, 2024, at 10:30 a.m. Eastern Time, accessible virtually at www.virtualshareholdermeeting.com/ALNY2024.
• Stockholders can vote on proposals until May 15, 2024, at 11:59 PM ET, or until May 13, 2024, at 11:59 PM ET for shares held in a 401(k) Plan.
• The meeting will include voting on the election of four Class II director nominees: Dennis A. Ausiello, M.D., Olivier Brandicourt, M.D., Peter N. Kellogg, and David E.I. Pyott.
• A non-binding advisory vote will be held to approve the compensation of Alnylam's named executive officers.
• Stockholders will also vote to ratify the appointment of PricewaterhouseCoopers LLP as the company's independent auditors for the fiscal year ending December 31, 2024.
• Proxy materials, including the Proxy Statement, Annual Report on Form 10-K, and Annual Report to Stockholders, are available online or can be requested via mail, phone, or email before May 2, 2024.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, indicating a neutral to slightly positive sentiment as it reflects normal corporate governance processes.

Positives

• The virtual format of the annual meeting allows for broader accessibility for shareholders.
• Shareholders have multiple options for accessing proxy materials and voting, including online, phone, and email.
• The proposals include standard corporate governance matters such as director elections, executive compensation, and auditor ratification.

Industry Context

This announcement is a routine part of corporate governance for publicly traded companies, ensuring shareholders have the opportunity to participate in key decisions.

Stakeholder Impact

• Shareholders have the opportunity to influence the company's direction through voting.
• The outcome of the votes on director elections and executive compensation will impact the company's leadership and management structure.

Next Steps

• Shareholders should review the proxy materials and vote on the proposals by the specified deadlines.
• Alnylam will hold its Annual Meeting on May 16, 2024.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Voting, Directors, Executive Compensation, Auditor, Alnylam Pharmaceuticals